Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01537471 · ClinicalTrials.gov registry record · Phase 1
The Effects of Antihistamines on Pre-Pulse Inhibition
A Phase 1 study, sponsored by Duke University.
- Completed
- Registry status
- Phase 1
- Development phase
- 117
- Enrollment target
NCT01537471 is a Phase 1 study that has completed, run by Duke University. The registered enrollment target is 117 participants.
The verdict
NCT01537471, a Phase 1 study, has completed, sponsored by Duke University.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 117 participants
- Enrollment target
Study Summary
The purpose of the investigators research is to test whether problems people have with processing their senses (feeling overwhelmed, distracted or upset by sounds and other stimuli) can be lessened by meclizine, a drug found in many over the counter antihistamines, which are medicines used for things like allergies, sleep problems, or the common cold.
Interventions
- DRUG Placebo
- DRUG Meclizine
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 117 participants |
| Start Date | 2012-01 |
| Est. Completion | 2012-09 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01537471
The ClinicalTrials.gov registry entry for NCT01537471 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 117 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Duke University, which has 1,725 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which Placebo is the first listed.
NCT01537471 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01537471 about?
NCT01537471 is a clinical study titled "The Effects of Antihistamines on Pre-Pulse Inhibition". The purpose of the investigators research is to test whether problems people have with processing their senses (feeling overwhelmed, distracted or upset by sounds and other stimuli) can be lessened by meclizine, a drug found in many over the counter antihistamines, which are medicines used for thing...
What is the current status of trial NCT01537471?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 117 participants. The study started on 2012-01. Estimated completion is 2012-09.
What interventions are being tested in trial NCT01537471?
The interventions under investigation include: Placebo (DRUG), Meclizine (DRUG).
Who is sponsoring clinical trial NCT01537471?
This trial is sponsored by Duke University, which has 1,725 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.